Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: A systematic review of economic evidence

Systematic Review of the Literature on C

Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection

✍ Tatyana A. Shamliyan; James R. Johnson; Roderick MacDonald; Aasma Shaukat; Jian- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Clinical outcomes in adults with chronic

Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence

✍ Brent C. Taylor; Jian-Min Yuan; Tatyana A. Shamliyan; Aasma Shaukat; Robert L. K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

We systematically reviewed the literature on the extent to which population characteristics or clinical features predict groups of individuals likely to develop advanced liver disease or die from chronic infection with hepatitis B virus (HBV). We searched Medline to include studies with reported cir

Effect of antiviral therapy on circulati

Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C

✍ C. Sgier; B. Müllhaupt; T. Gerlach; D. Moradpour; F. Negro; P. J. Malé; M. H. He 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Cost-effectiveness of peginterferon alfa

Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

✍ Sean D Sullivan; David L Veenstra; Pei-Jer Chen; Ting-Tsung Chang; Wan-Long Chua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Clinical utility of hepatitis B surface

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

✍ Yun-Fan Liaw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin

Clinical utility of hepatitis B surface

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

✍ Yun-Fan Liaw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin